Pneumotox. vs iBronch
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Pneumotox.
This app aids in diagnosing respiratory and cardiac diseases suspected of being drug-induced. It provides extensive information and bibliography from over 35,000 reviewed references, organized by causative drugs and respiratory patterns. It helps assess drug causality and offers diagnostic prompts.
- Diagnose drug-induced respiratory diseases
- Extensive bibliography from 35,000+ references
- Organized by causative drugs and respiratory patterns
- Drug causality assessment tool
- Diagnostic prompts and Naranjo scale integration
- Information on various drug administration routes
Read full descriptionHide full description
Pneumotox®: The drug-induced/iatrogenic respiratory disease website & App. The companion website and App Cardiotox® cover drug-induced cardiotoxicity. By Philippe Camus MD. Professor (emeritus) - Board-certified in pulmonary medicine and cardiology,- Université Bourgone-Europe, Dijon, France. Pneumotox is an aid to the diagnosis and management of respiratory diseases and reactions suspected of being induced by drugs, chemicals, and of iatrogenic origin. Causality assessment and exact diagnosis are the full responsibility of the user. Pneumotox is designed to provide regularly-updated information on drugs causing pulmonary toxicity (>1,700 agents), patterns of involvement (>820) and bibliography (>10,700 as of August 2026) within a few minutes. That may be the crux in emergency situations. Yet, double-checking in and from other sources is indicated. Pneumotox rests on a bibliographic repository built since 1978, which amounts to >50,000 references overall, the vast majority of which is indexed in PubMed. All references were and are carefully reviewed for reliability and causality by the founder, then indexed under the corresponding drug or agent in Pneumotox. Pneumotox can be assessed by causative drug(s), chemicals, herbals, substances of abuse, inhaled incl. e-cigarettes, vaping, inhalants, gases, ionizing radiations (providing the list of patterns), or by patterns of involvement (providing the list of causal drugs/agents). Drug names are generic (International Nonproprietary Names (INN), alphabetical), not brand ones. It may be appropriate to check the exact composition of any proprietary drug, as any other added substance or excipient can be pneumotoxic. Matching generic and brand names which differs with country is the responsibility of the user. Patterns are grouped by families according to the main anatomic site of involvement. If a drug or drug reaction is listed in Pneumotox, that does not equate the patient is demonstrating toxicity. A “Diagnosing DIRD” window in Pneumotox (top panel) may help secure the diagnosis. Lack of case or cases in the literature or in Pneumotox does not exclude a diagnosis of drug toxicity as there may be unpublished cases, you may be seeing the first case ever, or we may have overlooked some information. In such situations, please inform us; Pneumotox cannot be held responsible. Pneumotox can be contacted by mail 7/365 for complementary information, tailored literature, and/or data on rechallenge with the drug. In any patient, particularly the ones with acute respiratory failure, ARDS or acute bronchospasm, exposure to drugs, substances, and/or chemicals must be done exhaustively with the patient, and if needed with the family, health professionals, pharmacy and/or law enforcement personel. And prompt removal of the drug can be lifesaving. Caution: drug withdrawal can produce a flare of the underlying condition for which the drug was exactly given. Deliberate rechallenge can be hazardous as fatal relapse of the respiratiory reaction can supervene. Early sampling of body fluids for drug and/or metabolites is indicated as early as possible, particularly in the severely ill. Knowledge of toxidromes and antidotes capable of countering adverse effects of drugs or chemicals is essential (ex: PMID ). Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies. They may host more and/or undisclosed information. Patients should be reassured as such incidents are rare oveall. If needed, they are invited to consult with their treating physicians. Monitoring common causal agents (with red digits in stars) for impending toxicity is strongly advised. You may contact Pneumotox anytime through the contact window. ALL RIGHTS RESERVED The current version of Pneumotox website and App were developed by Akyos Communication Dijon France, under the guidance of Philippe Camus MD
iBronch
Read full descriptionHide full description
Bronchoscopy is a procedure in which physicians are able to visualize the trachea and the bronchi that supply ventilation to the lungs. This is usually done under some form of anesthesia or sedation, and there is a learning curve in taking on this common operation. Bronchoscopy requires skill and patience to obtain the views needed for a complete study. iBronch uses images from an actual bronchoscopy to show the user typical views of a normal trachea-bronchial tree. Because its a simulation and does not involve a real patient, it can be used to familiarize oneself on the expected images seen on real patients.
Screenshots
Verdict
Pneumotox. and iBronch are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Pneumotox. ships an update every 42 months, iBronch every 56 months. The most recent releases landed on October 10, 2026 and October 14, 2026 respectively.
| Parameter | Pneumotox. | iBronch |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (7 ratings) — better | — |
| Positive reviews | 50.0% of reviews | — |
| Number of ratings | 7 — better | — |
| Update frequency | Every 42 months — better | Every 56 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad — better | iPad |
| Requires iOS | 16.4 — better | 17.0 |
| Further details — not scored | ||
| Size | 48 MB | 14 MB |
| Age rating | 17+ | 4+ |
| Developer | Philippe Camus | Bender Apps, LLC |
In-app purchases
Pneumotox.
No in-app purchases
iBronch
No in-app purchases
Questions
Is Pneumotox. free?
Is iBronch free?
Do Pneumotox. or iBronch have ads?
Which is updated more often, Pneumotox. or iBronch?
Other comparisons















